Mansen YuMD

Publications

• 2026

  A new HLA genotyping algorithm to show accuracy and concordance between tumor and normal samples.

  Journal of Clinical Oncology
• 2026

  Minimal Residual Disease Positivity at 3 Months Post Ciltacabtagene Autoleucel Identifies Patients at Risk of Early Relapse

  Transplantation and Cellular Therapy
• 2025

  Long-term follow-up of venetoclax therapy in AL amyloidosis

  Blood
• 2025

  The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation

  Leukemia
• 2024

  Prevalence of metabolic comorbidities and viral co-infections in monoclonal gammopathy: a retrospective analysis

  LeukemiaRCR 0.000 citesPMID 39164408
• 2024

  Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)–targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM).

  Journal of Clinical Oncology
• 2024

  P-088 Evaluating T-cell Fitness Pre B-Cell Maturation Antigen (BCMA)-Targeted T-Cell Redirection Therapies (TRT) as a Predictive Marker for Efficacy/Toxicity in Relapsed/Refractory Multiple Myeloma (RRMM)

  Clinical Lymphoma Myeloma and Leukemia
• 2020

  Islet transplantation in the subcutaneous space achieves long-term euglycaemia in preclinical models of type 1 diabetes.

  Nature metabolismfirst authorRCR 4.7589 citesPMID 32895576
• 2019

  Maintenance therapy with either Lenalidomide or Bortezomib equally improves PFS and OS in High Risk Myeloma initially treated with Autotransplant.

  Clinical Lymphoma Myeloma and Leukemia
• 2019

  USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model

  Experimental Hematology
• 2018

  Two distinct sites of client protein interaction with the chaperone cpSRP43.

  The Journal of biological chemistryRCR 0.196 citesPMID 29669809